
TruScreen Group Investor Relations Material
Latest events

H1 2025
28 Nov, 2024

AGM 2024 Presentation
2 Sep, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from TruScreen Group Limited
Access all reports
TruScreen Group Limited is a New Zealand-based medical technology company specializing in the development and commercialization of real-time cervical cancer screening devices. The company’s flagship product uses proprietary sensor technology and algorithms to detect precancerous and cancerous cells in cervical tissue, providing an alternative to traditional smear tests. TruScreen’s devices are designed for use in various healthcare settings, particularly in regions with limited access to laboratory-based screening methods, aiming to improve early detection and accessibility. The company is headquartered in Auckland, New Zealand, and its shares are listed on the NZX.
Key slides for TruScreen Group Limited


AGM 2024 Presentation
TruScreen Group Limited


AGM 2024 Presentation
TruScreen Group Limited
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
TRU
Country
🇳🇿 New Zealand